Press Releases


CollabRx, Sengenics Partner on Cancer Diagnostics

CollabRx today announced a deal with Sengenics to incorporate each other’s products into molecular diagnostics tests and reports aimed at cancer.   Under the terms of the agreement, Sengenics will integrate CollabRx’s interpretive content resources into its cancer exome sequencing


Read More »

FEATURED PRODUCTS

IMMUNOME™

High-throughput
sero-profiling platform

CTA array

Screening of 200+
cancer-testis antigens

Custom array

Flexible format for
high-throughput screening

1996 – 2019 © Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361 

1996 – 2019 © Sengenics All rights reserved 

X